Jefferies Initiates AptarGroup(ATR.US) With Buy Rating, Announces Target Price $215

富瑞集团首予AptarGroup(ATR.US)买入评级，目标价215美元

moomoo资讯 · 2024/10/14 18:32 · 评级/大行评级

Jefferies analyst Daniel Rizzo initiates coverage on $AptarGroup (ATR.US)$ with a buy rating, and sets the target price at $215.

According to TipRanks data, the analyst has a success rate of 68.0% and a total average return of 16.5% over the past year.

AnalystRecentRatingAutoNews_202226_20241014_5f047c7ccdb6d3291d12044d59c0f6ed0c4e6b8c_1728999026063961_mm_en

Furthermore, according to the comprehensive report, the opinions of $AptarGroup (ATR.US)$'s main analysts recently are as follows:

In discussing the packaging and containers industry ahead of quarterly results, it is believed that the third quarter saw a sequential improvement in demand, though expectations are tempered due to consumer and industrial sector caution. The perspective is that the industry's most challenging period has passed, but forecasts remain conservative with the anticipation of volumes remaining steady, rather than a low single-digit increase for the year. A full recovery is projected to extend into the first half of 2025, with a preference for certain companies in the sector as the ones to watch as the quarter's results approach.
AptarGroup's Pharma segment is anticipated to spearhead an 8.5% annual EBITDA growth through 2026, driven by a robust pipeline of new products including delivery systems for GLP-1 drugs, over-the-counter Narcan, and Neffy. This growth is expected to align the stock's valuation more closely with its peers in the healthcare packaging sector.

Note:

TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.

Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.

TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.

富瑞集团分析师Daniel Rizzo首予$AptarGroup (ATR.US)$买入评级，目标价215美元。

根据TipRanks数据显示，该分析师近一年总胜率为68.0%，总平均回报率为16.5%。

AnalystRecentRatingAutoNews_202226_20241014_5f047c7ccdb6d3291d12044d59c0f6ed0c4e6b8c_1728999026063961_mm_sc

此外，综合报道，$AptarGroup (ATR.US)$近期主要分析师观点如下：

在季度业绩公布之前讨论包装和容器行业时，人们认为第三季度的需求连续改善，尽管由于消费者和工业部门的谨慎态度，预期有所减弱。前景是，该行业最具挑战性的时期已经过去，但预测仍然保守，预计今年的销量将保持稳定，而不是个位数的低增长。预计全面复苏将持续到2025年上半年，随着本季度业绩的临近，该行业的某些公司将优先考虑该行业的某些公司。
预计到2026年，AptarGroup的制药板块将带头实现8.5％的年度息税折旧摊销前利润增长，这得益于包括 GLP-1 药物输送系统、非处方Narcan和Neffy在内的强大新产品管线。预计这种增长将使该股的估值与医疗保健包装领域的同行更加接近。

提示:

TipRanks为独立第三方，提供金融分析师的分析数据，并计算分析师推荐的平均回报率和胜率。提供的信息并非投资建议，仅供参考。本文不对评级数据和报告的完整性与准确性做出认可、声明或保证。

TipRanks提供每位分析师的星级，分析师星级代表分析师所有推荐的过往表现，通过分析师的总胜率和平均回报率综合计算得出，星星越多，则该分析师过往表现越优异，最高为5颗星。

分析师总胜率为近一年分析师的评级成功次数占总评级次数的比率。评级的成功与否，取决于TipRanks的虚拟投资组合是否从该股票中产生正回报。

总平均回报率为基于分析师的初始评级创建虚拟投资组合，并根据评级变化对组合进行调整，在近一年中该投资组合所获得的回报率。

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。更多信息

Jefferies Initiates AptarGroup(ATR.US) With Buy Rating, Announces Target Price $215

Jefferies Initiates AptarGroup(ATR.US) With Buy Rating, Announces Target Price $215

风险及免责提示

声明